Clinical Trial Update: Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical study evaluating Chinese medicine plus targeted therapy maintenance in advanced pulmonary adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Adenocarcinoma

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Cancer | Phase 3 | Status: COMPLETED